Datopotamab Biosimilar - Research Grade

Human

TACSTD2

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects TACSTD2

Blue ice

Trophoblast cell-surface antigen 2 (TACSTD2/TROP2) is over-expressed on numerous epithelial cancers and a leading antibody-drug-conjugate target in oncology research. This recombinant anti-human TACSTD2 monoclonal is an unconjugated, non-therapeutic analog of datopotamab, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Researchers apply it in functional assays, internalisation and binding studies, ADC-development workflows, reproducible controls, and in vivo tumour models, relying on its consistency for sustained, heavy-usage epithelial-cancer research.

tumor-associated calcium signal transducer 2, membrane component chromosome 1 surface marker 1, M1S1, gastrointestinal tumor-associated antigen GA7331, pancreatic carcinoma marker protein GA733-1, epithelial glycoprotein-1, EGP-1, trophoblast antigen-2, c

P09758

ICH3002

https://www.imgt.org/mAb-DB/